Search

Search Constraints

You searched for: Author/Creator Hansel, K.

Search Results

1. A 52‐week update of a multicentre real‐life experience on effectiveness and safety of risankizumab in psoriasis. (19th September 2021)

2. A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16‐week real‐life experience during the COVID‐19 pandemic. (8th November 2020)

6. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic. (1st January 2022)